Anticancer Composition Using Herbal Extracts to Reduce Chemotherapy Toxicity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, particularly chemotherapy and radiotherapy, cause significant damage to normal tissues and are often ineffective in enhancing immunity, regulating internal circulation, and expelling cancer toxins, leading to poor therapeutic outcomes and high economic burdens for patients.
Innovation Solution
A broad-spectrum anticancer pharmaceutical composition comprising Rosa roxburghii, Phyllanthus emblica, Punica granatum, Garcinia mangostana, Citrus limon, coconut, walnut, Rhizoma gastrodiae, Lucid ganoderma, Moringa oleifera, Radix ranunculi ternati, and Rhizoma paridis, which is formulated to enhance immunity, regulate internal circulation, and expel cancer toxins, using traditional Chinese medicine principles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional radiotherapy and chemotherapy are used to treat cancer, then tumor cells can be killed, but normal tissues are damaged and immunity is weakened
Solution Approach 1:
The patent uses a composite pharmaceutical composition containing multiple traditional Chinese medicine ingredients (Hedyotis diffusa, Scutellaria barbata, Curcuma longa, etc.) combined in specific proportions. This composite approach allows the formulation to achieve cancer-fighting effects while reducing the toxic side effects on normal tissues that occur with conventional single-agent chemotherapy or radiotherapy
Solution Approach 2:
The patent introduces traditional Chinese medicine compounds as intermediary substances that mediate between the harmful cancer cells and healthy human tissues. These herbal compounds selectively target cancer cells through multiple mechanisms (inducing apoptosis, inhibiting angiogenesis, modulating immune response) while being gentler on normal tissues compared to conventional chemotherapy agents
2Object-affected harmful factors
If conventional chemotherapy is used to treat cancer, then tumor growth can be inhibited, but immunity is suppressed and side effects occur
Solution Approach 1:
The patent incorporates ingredients that create a feedback mechanism to enhance immune function. The formulation includes compounds that stimulate immune cells (macrophages, natural killer cells, T cells) to recognize and attack cancer cells, while also reducing the immunosuppressive effects of conventional chemotherapy. This creates a positive feedback loop where the treatment enhances the body's own immune surveillance and response
Solution Approach 2:
The patent changes the chemical and biological parameters of cancer treatment by using traditional Chinese medicine compounds with different mechanisms of action compared to conventional chemotherapy. These compounds work through pathways such as inducing apoptosis, inhibiting cell proliferation, blocking angiogenesis, and modulating the tumor microenvironment, thereby achieving cancer control while preserving immune function
3Object-affected harmful factors
If high-dose chemotherapy is administered to achieve better cancer control, then therapeutic effect improves, but economic burden and treatment complexity increase
Solution Approach 1:
The patent segments the cancer treatment approach into multiple herbal ingredients, each contributing different therapeutic mechanisms. This segmentation allows for a comprehensive anti-cancer effect through multiple pathways (apoptosis induction, proliferation inhibition, angiogenesis blocking, immune modulation) while using naturally occurring compounds that are more affordable than conventional high-dose chemotherapy regimens
Solution Approach 2:
The patent creates a universal pharmaceutical composition that addresses multiple aspects of cancer treatment simultaneously. The formulation provides anti-proliferative effects, pro-apoptotic activity, anti-angiogenic properties, and immune-modulating functions in a single multi-ingredient preparation, thereby simplifying treatment complexity and reducing the need for multiple separate interventions
Data Source
AI summary
The present invention discloses an anticancer pharmaceutical composition, comprising the following materials in parts by weight: 0.5-30 parts of fruits/leaves of Rosa roxburghii, 0.5-30 parts of fruits/leaves of Phyllanthus emblica, 0.5-30 parts of peel/seeds of Punica granatum, 0.5-30 parts of honey, 0.5-30 parts of flesh/pericarp of Garcinia mangostana, 0.5-30 parts of coconuts, 0.5-30 parts of pulp/peel of Citrus limon, 0.5-30 parts of raw walnuts, 0.1-5 parts of Rhizoma gastrodiae, 0.1-5 parts of Lucid ganoderma, 0.1-5 parts of seeds/leaves of Moringa oleifera, 0.01-2 parts of Radix ranunculi ternati and 0.01-2 parts of Rhizoma paridis.